Correlation Between Longmaster Information and Hubei Jumpcan

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Longmaster Information and Hubei Jumpcan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Longmaster Information and Hubei Jumpcan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Longmaster Information Tech and Hubei Jumpcan Pharmaceutical, you can compare the effects of market volatilities on Longmaster Information and Hubei Jumpcan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Longmaster Information with a short position of Hubei Jumpcan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Longmaster Information and Hubei Jumpcan.

Diversification Opportunities for Longmaster Information and Hubei Jumpcan

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Longmaster and Hubei is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Longmaster Information Tech and Hubei Jumpcan Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hubei Jumpcan Pharma and Longmaster Information is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Longmaster Information Tech are associated (or correlated) with Hubei Jumpcan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hubei Jumpcan Pharma has no effect on the direction of Longmaster Information i.e., Longmaster Information and Hubei Jumpcan go up and down completely randomly.

Pair Corralation between Longmaster Information and Hubei Jumpcan

Assuming the 90 days trading horizon Longmaster Information Tech is expected to generate 1.74 times more return on investment than Hubei Jumpcan. However, Longmaster Information is 1.74 times more volatile than Hubei Jumpcan Pharmaceutical. It trades about 0.15 of its potential returns per unit of risk. Hubei Jumpcan Pharmaceutical is currently generating about -0.06 per unit of risk. If you would invest  1,439  in Longmaster Information Tech on September 5, 2024 and sell it today you would earn a total of  171.00  from holding Longmaster Information Tech or generate 11.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Longmaster Information Tech  vs.  Hubei Jumpcan Pharmaceutical

 Performance 
       Timeline  
Longmaster Information 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Longmaster Information Tech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Longmaster Information sustained solid returns over the last few months and may actually be approaching a breakup point.
Hubei Jumpcan Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Hubei Jumpcan Pharmaceutical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hubei Jumpcan may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Longmaster Information and Hubei Jumpcan Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Longmaster Information and Hubei Jumpcan

The main advantage of trading using opposite Longmaster Information and Hubei Jumpcan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Longmaster Information position performs unexpectedly, Hubei Jumpcan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hubei Jumpcan will offset losses from the drop in Hubei Jumpcan's long position.
The idea behind Longmaster Information Tech and Hubei Jumpcan Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance